Medical Devices Apheresis Market is projected to grow up to 7.9% CAGR during the forecasting period 2021-2...

Apheresis Market is projected to grow up to 7.9% CAGR during the forecasting period 2021-2027

Apheresis is a medical technology by which one or more blood components can be acquired by processing of blood by utilizing an apheresis system. The left over components are then given back to the donor or patient while the process is going on or at the end of the process. The use of apheresis system in clinically ill patients is rising day by day, and it has been most widely used as the basic therapy or as a complement to other treatments for several diseases, such as hemolytic uremic syndrome, autoimmune disease, drug toxicities, thrombotic thrombocytopenic purpura, sepsis and fulminant hepatic failure. On contrary, the lack of skilled labour and complexes associated with the apheresis procedure are projected to limit the market growth. Presently, different types of apheresis procedures are mostly used as a part of treatment in various plasmapheresis, plateletpheresis, erythrocytapheresis, leukapheresis and photopheresis. 

Request for a sample report:

Key Driving Factors: Immense application of plasma therapy in the treatment of COVID-19 infected patients

The Apheresis market is projected to be positively impacted in the COVID-19 pandemic. This is due to the increasing application of plasma therapy in the treatment of the patients infected by COVID-19. Since, the plasma therapy has emerged to be a significant therapy for the coronavirus. Moreover, the US FDA conceded emergency usage of convalescent plasma therapy for the hospitalized patients with COVID-19. Thus, the apheresis system is used in collecting the convalescent plasma from completely recovered patients and transfers it to active patients as a source of antibodies.

The leading companies of the apheresis market from all the various regions are Fresenius SE & Co. KGaA, Haemonetics Corporation, Asahi Kasei Medical Co. Ltd., B. Braun Melsungen AG, Terumo BCT, Inc., Kaneka Corporation, Baxter International Inc., Cerus Corporation, Kawasumi Laboratories, Inc. and Nikkiso Co., Ltd. 

Opportunities: Application of apheresis for paediatric patients suffering from leukaemia and autoimmune disease

The application of therapeutic apheresis in paediatric treatment is projected to aid in growth of the market. Delivering the therapeutic apheresis to children is a considered as technologically difficult task. Various numbers of apheresis therapies are developed from research and trials on adult patients. However, as the prevalence of diseases which include leukemia and autoimmune disorders is surging among children. Since many efforts for developing new apheresis treatment methods are also increasing particularly developing for children which are going to serve as a potential opportunity in the market.

Apheresis Market based on End Users:

The end users of the apheresis market include blood collection centres and blood component providers, hospitals and transfusion centres and other end users. The significant end user of the apheresis is blood collection centres and blood component providers since it has the highest share in the market. This is due to the increasing number of blood component donations, rising number of blood centres and growing awareness regarding the blood collection.   

The Apheresis market report has been categorized as below

By product

·        Devices

·        Disposables

·        Magnetic & Bioprinted 3D Cell Cultures

By Application

·        Plasmapheresis

·        Plateletpheresis

·        Erythrocytapheresis

·        Leukapheresis

·        Photopheresis

By Technology

·        Membrane Filtration

·        Centrifugation technology

·        Membrane Filtration

·        Centrifugation technology

·        Membrane Filtration

By Methods

·        Automated Blood Collection

·        Therapeutic Apheresis

By End Users

·        Blood Collection Centres and Blood Component Providers

·        Hospitals and Transfusion Centres

·        Other End Users

By Region

·        North America

·        Europe

·        Asia Pacific

·        Rest of the World

Access to Full Report Summary:

Published Date : April-2021